Literature DB >> 7082295

Action of rat liver cathepsin L on collagen and other substrates.

H Kirschke, A A Kembhavi, P Bohley, A J Barrett.   

Abstract

1. It has been found that cathepsin L is very susceptible to loss of activity through autolysis. When this is prevented by purification and storage of the enzyme as its mercury derivative, preparations are obtained with higher specific activity than previously. 2. Active-site titration shows, however, that even the new purification method does not give preparations in which the enzyme is 100% active. 3. Benzyloxycarbonylphenylalanylarginine 7-(4-methyl)coumarylamide has been discovered to be a very sensitive substrate for cathepsin L. Like all other known substrates for cathepsin L, however, it is also cleaved by cathepsin B. 4. Cathepsin L degrades insoluble collagen at pH 3.5 over 5-fold faster than at pH 6.0. The specific activity at pH 3.5 is 5-10-fold higher than that of cathepsin B (rat or human) or bovine spleen cathepsin N ('collagenolytic cathepsin'). 5. Qualitatively, the action of cathepsin L on collagen is similar to that of cathepsins B and N, i.e. selective cleavage of terminal peptides leads to conversion of beta- and higher components mainly to alpha-chains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082295      PMCID: PMC1163652          DOI: 10.1042/bj2010367

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1. 

Authors:  P Bohley; H Kirschke; J Langner; S Ansorge
Journal:  FEBS Lett       Date:  1969-11-12       Impact factor: 4.124

2.  Purification and characterization of phosphodiesterase activator from kidney. A lysosomal protease.

Authors:  G J Strewler; V C Manganiello
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

3.  Pepstatin-insensitive proteolytic activity of rat liver lysosomes. Isolation and purification of a new pepstatin-insensitive proteolytic enzyme from rat liver lysosomes.

Authors:  G N DeMartino; T W Doebber; L L Miller
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

Review 4.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Purification of bovine spleen collagenolytic cathepsin, (cathepsin N).

Authors:  A Ducastaing; D J Etherington
Journal:  Biochem Soc Trans       Date:  1978       Impact factor: 5.407

6.  A new assay for cathepsin B1 and other thiol proteinases.

Authors:  A J Barrett
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

7.  Cathepsin L. A new proteinase from rat-liver lysosomes.

Authors:  H Kirschke; J Langner; B Wiederanders; S Ansorge; P Bohley
Journal:  Eur J Biochem       Date:  1977-04-01

8.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  Human cathepsin H.

Authors:  W N Schwartz; A J Barrett
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

10.  Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

View more
  47 in total

1.  An approach to computer-aided inhibitor design: application to cathepsin L.

Authors:  S Sudarsanam; G D Virca; C J March; S Srinivasan
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

2.  Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration.

Authors:  Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan
Journal:  J Physiol Biochem       Date:  2010-08-02       Impact factor: 4.158

Review 3.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

4.  Cleavage of native type I collagen by human neutrophil elastase.

Authors:  W Kafienah; D J Buttle; D Burnett; A P Hollander
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.

Authors:  D Brömme; A Schierhorn; H Kirschke; B Wiederanders; A Barth; S Fittkau; H U Demuth
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

6.  The purification and properties of cathepsin L from rabbit liver.

Authors:  R W Mason; M A Taylor; D J Etherington
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

7.  Human liver cathepsin L.

Authors:  R W Mason; G D Green; A J Barrett
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

8.  Elevation of cathepsin L levels in the synovial lining of rabbits with antigen-induced arthritis.

Authors:  D J Etherington; M A Taylor; B Henderson
Journal:  Br J Exp Pathol       Date:  1988-04

Review 9.  Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins.

Authors:  Leo Tjäderhane; Fabio D Nascimento; Lorenzo Breschi; Annalisa Mazzoni; Ivarne L S Tersariol; Saulo Geraldeli; Arzu Tezvergil-Mutluay; Marcela R Carrilho; Ricardo M Carvalho; Franklin R Tay; David H Pashley
Journal:  Dent Mater       Date:  2012-08-16       Impact factor: 5.304

10.  Isolation and characteristics of collagenolytic enzyme produced by Candida albicans.

Authors:  H Kaminishi; Y Hagihara; S Hayashi; T Cho
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.